Gut and Azithromycin Mechanisms in Infants and Children II

PHASE4CompletedINTERVENTIONAL
Enrollment

449

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
Malaria
Interventions
DRUG

Azithromycin

Zithromax® for oral suspension is supplied in bottles containing azithromycin dehydrate powder equivalent to 1200mg per bottle and the following inactive ingredients: sucrose; tribasic anhydrous sodium phosphate; hydroxypropyl cellulose; xanthan gum; FD\&C Red #40; and flavoring including spray dried artificial cherry, crème de vanilla, and banana. After constitution, a 5mL suspension contains 200mg of azithromycin.

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Centre de Recherche en santé de nouna, Nouna

All Listed Sponsors
collaborator

Centre de Recherche en Sante de Nouna, Burkina Faso

OTHER_GOV

lead

University of California, San Francisco

OTHER

NCT04315272 - Gut and Azithromycin Mechanisms in Infants and Children II | Biotech Hunter | Biotech Hunter